Logotype for Sila Realty Trust Inc

Sila Realty Trust (SILA) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sila Realty Trust Inc

Q2 2024 earnings summary

1 Jul, 2026

Executive summary

  • Listed on NYSE on June 13, 2024, following a one-for-four reverse stock split and share class reclassification; completed first earnings call as a public company and a $50M Dutch Auction tender offer, repurchasing 2.2M shares (3.9% of shares outstanding).

  • Portfolio consists of 137 healthcare properties and two undeveloped parcels totaling 5.3 million rentable square feet, with a 97.5% leased rate and 8.2 years weighted average lease term as of June 30, 2024.

  • Acquired seven healthcare properties for $135.7M in H1 2024, including a $10.8M outpatient building in Q2 and a $28.3M inpatient facility post-quarter.

  • Emphasized disciplined capital deployment, strong balance sheet, and readiness for scalable growth.

Financial highlights

  • Q2 2024 GAAP net income was $4.6M ($0.08/share), up from $3.9M ($0.07/share) in Q2 2023; first half 2024 net income was $19.6M, up from $18.1M.

  • Cash NOI for Q2 2024 was $39.9M, down 5.8% year-over-year, mainly due to vacancies from GenesisCare and Steward Health Care.

  • AFFO for Q2 2024 was $30.8M ($0.54/share), down from $31.6M ($0.55/share) in Q2 2023; first half 2024 AFFO rose 5% to $69.1M ($1.20/share).

  • Rental revenue for Q2 2024 was $43.6M, down 3.1% year-over-year; six-month rental revenue was $94.2M, down 0.4%.

  • Dividend payout to AFFO ratio was 75% for Q2 2024; $0.40 per share in quarterly dividends declared.

Outlook and guidance

  • Targeting 10%-15% annual balance sheet growth, with acquisition cap rates in the 7%-8% range.

  • Board authorized a distribution of $0.1333 per share payable August 15, 2024, annualized at $1.60 per share.

  • Management expects sufficient liquidity for the next twelve months, supported by $87M cash, operations, and $500M undrawn credit facility.

  • NOI and G&A for Q2 2024 are considered indicative of run-rate, with future adjustments for recent acquisitions and interest rate hedge expirations.

  • Conservative leverage target of 4-5x net debt to EBITDARE, with flexibility to run lower or higher.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more